These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17448109)

  • 41. A struggle to SURVIVE: to abandon or not to abandon levosimendan?
    Butler J; Giamouzis G; Giannakoulas G
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):401-2. PubMed ID: 17701453
    [No Abstract]   [Full Text] [Related]  

  • 42. Can we believe in levosimendan?
    Follath F
    Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391
    [No Abstract]   [Full Text] [Related]  

  • 43. [Calcium mobilizers and calcium sensitizers].
    Arai M
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():417-22. PubMed ID: 22724240
    [No Abstract]   [Full Text] [Related]  

  • 44. Is there a place for levosimendan in the intensive care unit?
    Simes DC
    Crit Care Resusc; 2007 Dec; 9(4):395. PubMed ID: 18052906
    [No Abstract]   [Full Text] [Related]  

  • 45. Levosimendan and quality of life.
    Papadopoulos CE; Zioutas DG; Dalamaga EG
    Hellenic J Cardiol; 2010; 51(1):81-2. PubMed ID: 20118051
    [No Abstract]   [Full Text] [Related]  

  • 46. [Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report].
    Biegus J; Zymliński R; Kulej K; Szachniewicz J; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2013; 71(3):275-8. PubMed ID: 23575784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
    Wikström BG
    Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical significance of acute neurohormonal response after levosimendan treatment.
    Giannakoulas G; Giannoglou G; Vassilikos V; Martiadou K; Kalpidis P; Parharidis G; Louridas G
    Am J Cardiol; 2006 Oct; 98(8):1123-4. PubMed ID: 17027590
    [No Abstract]   [Full Text] [Related]  

  • 49. Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy.
    Tsagalou EP; Nanas JN
    Resuscitation; 2006 Jan; 68(1):147-9. PubMed ID: 16325323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 51. Positive inotropy for acute heart failure complicating myocardial infarction.
    Coats AJ
    Eur Heart J; 2002 Sep; 23(18):1405-6. PubMed ID: 12208215
    [No Abstract]   [Full Text] [Related]  

  • 52. Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failure.
    Mueller T; Gegenhuber A; Haltmayer M
    Int J Cardiol; 2005 Oct; 104(3):355-6; author reply 357-8. PubMed ID: 15950299
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in positive inotropic therapy: levosimendan.
    Frishman WH
    Crit Care Med; 2003 Sep; 31(9):2408-9. PubMed ID: 14501979
    [No Abstract]   [Full Text] [Related]  

  • 55. The case for levosimendan.
    De Keulenaer BL
    Crit Care Resusc; 2008 Sep; 10(3):180. PubMed ID: 18798714
    [No Abstract]   [Full Text] [Related]  

  • 56. Levosimendan use in several scenarios of acute heart failure.
    Tavares M; Andrade AC; Mebazaa A
    Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of levosimendan on B-type natriuretic peptide levels in patients with advanced heart failure: a meta-analysis].
    Xu ZD; He WX; Zhao YF; Xia SX; He B; Yang T; Cao DX; Peng SL; Li J; Cao MH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2027-9. PubMed ID: 19861257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inotropes in the management of acute heart failure.
    Petersen JW; Felker GM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardioprotection: a new paradigm in the management of acute heart failure syndromes.
    Maytin M; Colucci WS
    Am J Cardiol; 2005 Sep; 96(6A):26G-31G. PubMed ID: 16181820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Levosimendan in acute heart failure: past, present and future].
    Delgado JF
    Rev Esp Cardiol; 2006 Apr; 59(4):309-12. PubMed ID: 16709382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.